RT Journal Article
SR Electronic
T1 A Novel Heuristic Global Algorithm to Predict the COVID-19 Pandemic Trend
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.16.20068445
DO 10.1101/2020.04.16.20068445
A1 Asteris, Panagiotis G.
A1 Douvika, Maria
A1 Karamani, Christina
A1 Skentou, Athanasia
A1 Daras, Tryfon
A1 Cavaleri, Liborio
A1 Armaghani, Danial Jahed
A1 Chlichlia, Katerina
A1 Zaoutis, Theoklis E.
YR 2020
UL http://medrxiv.org/content/early/2020/04/22/2020.04.16.20068445.abstract
AB Background Mathematical models are useful tools to predict the course of an epidemic. The present manuscript proposes a heuristic global algorithm for predicting the COVID-19 pandemic trend.Methods The proposed method utilizes a Gaussian-function-based algorithm for estimating how the temporal evolution of the pandemic develops by predicting daily COVID-19 deaths, for up to 10 days, from the day the prediction is made. This dataset, the number of daily deaths in each country or region, encapsulates information about (a) the quality of the health system of each country or region, (b) the age profile of the country’s/region’s population, and (c) environmental and other conditions.Findings The validity of the proposed heuristic global algorithm has been tested in the case of China (at different temporal stages of the pandemic), a country where the disease trend seems to have run its course. It has been applied to ten countries/states/cities, namely California, Germany, China, Greece, Iran, Lombardia/Italy, New York, Sweden, United Kingdom and USA, for each one of which predictions have been obtained. The method has also been applied to the United States as a whole, as well as to the states of New York and California, in order to investigate how the pandemic is developing in different parts of the same country.Interpretation Based on the predicted findings, the proposed algorithm seems to offer a robust and reliable method for revealing the SARS-CoV-2 temporal dynamics and disease trend, as such, can be a useful tool for the relevant authorities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to the manuscript are available